©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Vesicular

L

-Glutamate Transporter in Microvesicles from Bovine Pineal Glands

DRIVING FORCE, MECHANISM OF CHLORIDE ANION ACTIVATION, AND SUBSTRATE SPECIFICITY (*)

(Received for publication, May 16, 1995; and in revised form, July 19, 1995)

Yoshinori Moriyama (1)(§) Akitsugu Yamamoto (2)

From the  (1)Marine Biological Laboratory, Graduate Department of Gene Sciences, Faculty of Sciences, Hiroshima University, Mukaishima, Hiroshima 722, Japan and the (2)Department of Physiology, Kansai Medical University, Moriguchi, Osaka 570, Japan

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Pinealocytes, endocrine cells that synthesize and secrete melatonin, possess a large number of synaptic-like microvesicles (MVs) containing the L-glutamate transporter (Moriyama, Y., and Yamamoto, A.(1995) FEBS Lett., 367, 233-236). In this study, the L-glutamate transporter in MVs isolated from bovine pineal glands was characterized as to its driving force, requirement of anions, and substrate specificity. Upon the addition of ATP, the MVs accumulated L-glutamate. The uptake was significantly dependent on the extravesicular Cl concentration, being negligible in the absence of Cl and maximum at 2-5 mM and decreasing gradually at 20-100 mM. The membrane potential (inside positive) was maximum at 0-10 mM Cl and then decreased gradually depending on the Cl concentration, whereas a pH gradient was practically absent without Cl and increased gradually up to 100 mM Cl. Ammonium acetate or nigericin plus K, a dissipator of a pH gradient, had little effect on or was slightly stimulatory toward the uptake, whereas valinomycin plus K inhibited both formation of the membrane potential and the glutamate uptake to similar extents. The ATP- and Cl-dependent glutamate uptake was inhibited by fluoride, iodide, or thiocyanate, without vacuolar H-ATPase being affected. An anion channel blocker, 4,4`-diisothiocyanatostilbene-2,2`-disulfonic acid, similarly inhibited the glutamate uptake in a Cl protectable manner. Furthermore, ATP- and glutamate-dependent acidification of MVs was observed when 4 mM Cl was present. Among more than 50 kinds of glutamate analogues tested, only a few compounds, including 1-aminocyclohexane-trans-1,3-dicarboxylic acid, caused similar acidification. A good correlation was observed between the acidification and the inhibition of glutamate uptake by glutamate analogues. These results indicated that 1) the major driving force of the glutamate uptake is the membrane potential, 2) Cl regulates the glutamate uptake, probably via anion-binding site(s) on the transporter, and 3) the transporter shows strict substrate specificity. Hence, the overall properties of the vesicular glutamate transporter in the MVs well matched those of the synaptic vesicle glutamate transporter. We concluded that the vesicular glutamate transporter, being similar if not identical to the neuronal counterpart, operates in endocrine cells.


INTRODUCTION

Pinealocytes are parenchymal endocrine cells of pineal glands that synthesize and secrete melatonin into the blood(1, 2, 3) . At least two kinds of secretory vesicle-like organelles have been identified in pinealocytes: dense core granules, which are speculated to be involved in the storage and secretion of melatonin and some neuropeptides such as arginine vasotocin(3, 4) , and a large number of synaptic-like microvesicles (MVs) (^1)containing synaptophysin(5) . Although histochemical evidence indicated that MVs are distinct from neuronal synaptic vesicles in their lack of synapsin I, the possible participation of MVs in some secretory pathways in pinealocytes was also speculated(5) .

Very recently, we established a procedure for isolating MVs from bovine pineal glands and found that these vesicles were actually devoid of synapsin I but possess synaptotagmin and synaptobrevin 2, proteins necessary for vesicular transport(6) . Furthermore, the MVs specifically accumulated L-glutamate in an energy-dependent manner(6) . These results suggested that MVs are the organelles in pinealocytes that store and secrete L-glutamate. Therefore, it seems likely that pinealocytes possess novel glutamate-evoked signal transducing systems.

To reveal the entire features of the putative MV-mediated signal transduction systems in pinealocytes, at first we focused on the glutamate transporter in MVs. So far, the ATP-dependent vesicular glutamate transporter has been identified in brain synaptic vesicles(7, 8, 9, 10, 11, 12, 13) . Because the glutamate transporter in pineal MVs is the first example of a vesicular glutamate transporter outside neuronal cells, it is of interest to determine the mechanistic difference or similarity between glutamate transporters of the neuronal and endocrine origins. In this study, we characterized the glutamate transporter in pineal MVs and obtained evidence that it is quite similar to that in brain synaptic vesicles.


EXPERIMENTAL PROCEDURES

Isolation of MVs from Pineal Glands

The details are given in (6) . In brief, bovine pineal glands (about 50 glands for one preparation) obtained from a local slaughterhouse within a few hours after killing were washed, cut into small pieces with scissors, suspended in 80 ml of SME buffer (20 mM MOPS-Tris (pH 7.0) containing 0.3 M sucrose, 5 mM EDTA, 5 µg/ml pepstatin A, and 5 µg/ml leupeptin), and then homogenized in a Dounce homogenizer. The homogenate was centrifuged at 900 times g (R(max)) for 10 min, and then the resultant supernatant was centrifuged at 11,000 times g (R(max)) for 20 min. The resultant supernatant was centrifuged at 130,000 times g for 40 min. The resultant pellet was washed once, suspended in 2.5 ml of SME buffer (crude MV fraction), and then applied to a discontinuous sucrose density gradient (0.7 ml of 1.8, 1.2, 1.0, 0.8, 0.6, and 0.4 M sucrose containing 5 µg/ml pepstatin A and 5 µg/ml leupeptin). After centrifugation at 207,700 times g (R(max)) for 3 h, four distinct bands were obtained. The top broad white band was collected, diluted 5-fold with SME buffer, and then centrifuged at 139,000 times g for 40 min. The pellet (purified MVs) was suspended in SME buffer and stored at -85 °C until use. More than 95% of the vesicles in the final preparation were MVs (relatively clear small vesicles with an average diameter of 50 nm containing synaptophysin and V-ATPase), as revealed on conventional and immunoelectron microscopy using an anti-synaptophysin monoclonal antibody(6) . The MVs were distinct from synaptic vesicles in their lack of synapsin I(6) .

Transport Assay

Unless otherwise specified, the uptake of radioactive L-glutamate by MVs was assayed in 0.5 ml of 20 mM MOPS-Tris (pH 7.0) containing 4 mM KCl, 0.3 M sucrose, 2 mM magnesium acetate, 2 mM ATP (Tris salt, pH 7.0), and MVs (about 50 µg of protein) (standard assay conditions). The assay was started at 30 °C by the addition of radioactive glutamate (2.5 µCi, 0.1 mM). Aliquots (100 µl) were taken at intervals and filtered through 0.45 mM Millipore filters (type HA). Ater extensive washing, the remaining radioactivity on the filters was counted with a liquid scintillation counter.

The formation of DeltapH (inside acidic) was measured by means of acridine orange fluorescence quenching as described previously, the excitation and emission wavelength pair being 492 nm and 540 nm, respectively(11) . Delta (inside positive) was measured by means of oxonol-V fluorescence quenching (excitation, 580 nm; emission, 620 nm) (11) .

Chemicals

L-[2,3-^3H]Glutamate (638.3 GBq/mmol) was purchased from Amersham Corp. The glutamate analogues listed in Table 3and Table 4were from Tocris Neuramin, except for methyleneglutamate, -ethylglutamate, methylglutamate, aspartate, and -aminobutyrate, which were from Sigma. ATP (Tris salt) was from Sigma. DIDS was obtained from Dojindo Laboratories (Japan). Other chemicals were of the highest grade commercially available.






RESULTS

Requirement of ClforL-Glutamate Uptake by Pineal MVs

MVs purified from bovine pineal glands took up L-glutamate, which was coupled with an electrochemical proton gradient established by V-ATPase(6) . During the assaying glutamate uptake by pineal MVs, we noticed that a low concentration of Cl significantly enhanced the L-glutamate uptake, as shown in Fig. 1A. Cation species were not responsible for the activation (data not shown). The Cl concentration required for the maximum glutamate uptake was 2-5 mM, with the uptake decreasing gradually at higher concentrations (Fig. 1B). Only 6% of the maximum activity was observed in the absence of Cl (Fig. 1B). Chloride and bromide anions were equally effective for the activation (Fig. 1C). The nitrate, iodide, and gluconate ions were slightly effective, whereas the acetate and bicarbonate ions were not effective, and the fluoride and thiocyanate ions were inhibitory (Fig. 1C). These results indicated that the ATP-dependent glutamate uptake by pineal MVs is anion-sensitive and requires Cl.


Figure 1: Chloride anion-stimulated L-glutamate uptake into MVs. A, the time course of ATP-dependent L-glutamate uptake was measured as described under ``Experimental Procedures'' in the presence (open circles) or absence (closed circles) of 4 mM KCl. B, the Cl dose dependence of the activation of glutamate uptake at 5 min was measured according to the standard procedure in the presence of the indicated concentrations of KCl. C, the effects of various anions were assayed as described above except that the indicated potassium salts (4 mM each) were used instead of KCl. The results were expressed as activation fold, taking the glutamate uptake in the absence of salts (sucrose) as 1.0, and are presented as the means ± S.E. (average of 4 different experiments).



The requirement of a low concentration of Cl may be one of the significant properties of the glutamate uptake. The following alternative mechanisms may possibly explain the activation: one is direct interaction of Cl with the glutamate transporter and another is the necessity of Cl for the formation of an electrochemical proton gradient, because V-ATPase is an anion-sensitive proton pump(14, 15, 16) . To clarify the role of Cl in the glutamate uptake, we next analyzed the effects of anions on ATP-dependent membrane energization.

Characteristics of ATP-dependent Membrane Energization of Pineal MVs

Fig. 2shows the Cl-dependence of ATP-dependent formation of DeltapH (inside acidic) and Delta (inside positive) in MVs, as measured with fluorescent indicators. A proton conductor, 3,5-di-tert-butyl-4-hydroxybenzylidene malononitrile (SF6847) (0.5 µM), or a V-ATPase inhibitor, bafilomycin A1 (50 nM), inhibited the formation of both DeltapH and Delta, confirming that V-ATPase formed an electrochemical proton gradient across the MV membrane (Fig. 2, A and B). The formation of DeltapH was dependent on the exogenous Cl concentration; a little DeltapH was generated in the absence of Cl, but it increased linearly up to 20 mM and then gradually to 100 mM Cl (Fig. 2C). On the other hand, Delta was highest at 0-10 mM Cl and then decreased gradually depending on the Cl concentration (Fig. 2C). These results indicated that the formation of Delta prevented the formation of DeltapH electrically in the absence of Cl, and that the collapse of Delta due to Cl uptake, possibly through an anion channel or anion transporter, induced further acidification, as in the case of other endomembrane systems(16, 17, 18) . This was confirmed by the observation that Br, another substrate of the endomembrane anion channel (transporter)(19) , also induced the ATP-dependent acidification, whereas other anions, such as sulfate or acetate, which are not substrates for the anion channel, did not (Fig. 2A).


Figure 2: Effects of Cl and other anions on the ATP-dependent formation of DeltapH and Delta in pineal MVs. A, ATP-driven fluorescence quenching of acridine orange was measured in 20 mM MOPS-Tris buffer (pH 7.0) containing 0.3 M sucrose, 2 mM magnesium acetate, 2 µM acridine orange, and 20 µg of protein of purified MVs in the presence of the indicated salts (0.1 M), if otherwise stated. In an experiment shown in K-acetate + KCl (4 mM) and KCl + K-acetate, potassium acetate (0.1 M) plus KCl (4 mM) and KCl plus potassium acetate (0.1 M each) were included in the assay mixture, respectively. The increase in the acridine orange fluorescence on the addition of ATP was omitted from the figure because it is an artifact due to the interaction of the dye and ATP(46) . B, oxonol-V fluorescence quenching was measured in the same buffer as in A except that 5 µM oxonol-V was used instead of acridine orange. C, acridine orange (closed circles) and oxonol-V (open circles) fluorescence quenching were measured in the presence of the indicated concentrations of KCl and expressed as relative values, taking maximum quenching as 100%. Other additions: 1.0 mM ATP, 50 nM bafilomycin A1, and 5 mM ammonium acetate.



Energetics of ATP-dependent and Cl-activated Glutamate Uptake

The dose-dependent effects of Cl on the formation of DeltapH and Delta differed from those of the glutamate uptake (Fig. 1C), indicating clearly that DeltapH and Delta are not simply linked to the Cl-activated glutamate uptake. Two alternative possibilities as to the role of Cl can be considered. One is that Delta is the driving force and Cl acts as a co-factor or a coupling anion for the uptake. The other possibility is that Delta is a major driving force but that the small DeltapH present at a low concentration of Cl is also necessary for the uptake.

Then, we compared the effects of ionophores and the ammonium ion on the glutamate uptake, DeltapH and Delta (Table 1). To control the magnitude of DeltapH and Delta due to ionophores, 0.1 M potassium acetate was included in the assay medium as a K source, because this salt did not affect the Cl-stimulated glutamate uptake. Nigericin or ammonium acetate dissipated DeltapH without affecting or slightly increasing Delta. Under these conditions, glutamate uptake was not affected or slightly stimulated. Valinomycin, on the other hand, partially abolished Delta and inhibited glutamate uptake to similar extents. The combination of valinomycin and nigericin or ammonium acetate dissipated both DeltapH and Delta, resulting in almost complete inhibition of the glutamate uptake. These results indicated that the magnitude of glutamate uptake into MVs is correlated with the magnitude of Delta but not that of DeltapH. Thus, Delta seems to be the driving force for glutamate uptake in pineal MVs, although we could not completely rule out the participation of a small DeltapH in the glutamate transport.



Characteristics of a Putative Anion-binding Site in the Glutamate Transporter

The stimulatory effect of Cl, therefore, suggests the presence of a Cl-binding site in the glutamate transporter. To reveal the properties of this putative Cl-binding site, we investigated the effects of various anions on the Cl-stimulated glutamate uptake. As shown in Fig. 3A, the fluoride, iodide, thiocyanate, and nitrate ions were all inhibitory, whereas other anions had little effect. The inhibitory effect of the nitrate ion was due to a decrease in the magnitude of the driving force (loss of Delta) due to inhibitin of V-ATPase (Fig. 3B). On the other hand, the fluoride and thiocyanate ions under the concentrations used in this experiment had little effect on Delta (Fig. 3B), suggesting that the inhibition was due to direct interaction with the glutamate transporter. The iodide ion had a similar effect (not shown). The inhibition was reversible, and full activity was recovered after washing of the membranes (not shown).


Figure 3: Effects of anion species on Cl-stimulated glutamate uptake. A, the ATP-dependent glutamate uptake at 5 min in the presence of 4 mM KCl plus the indicated potassium salts (4 mM) is shown as the means ± S.E. (average of 4 experiments). The degree of Delta, as measured by means of oxonol-V fluorescence quenching under similar conditions, is also shown on the right as relative values. B, the F, I, SCN, and NO3 dose dependences of the inhibition of Cl-stimulated glutamate uptake (closed circles) and Delta (open circles) in the presence of 4 mM KCl are shown.



To find compounds that interact with the anion-binding site(s) irreversibly or that are more potent than thiocyanate, we tested several kinds of anion channel blockers. DIDS was found to be a strong inhibitor of the glutamate uptake (Table 2). DIDS also inhibited V-ATPase(19, 20) , the ID value being 3.8 µM. However, the ID value on inhibition of the glutamate uptake was only 0.3 µM. Furthermore, inhibition of the glutamate uptake by DIDS was prevented by Cl but not by acetate (Table 2). Taken together, these results suggested that the Cl-binding site(s) in the glutamate transporter can be occupied by F, thiocyanate, or DIDS. The chloride-binding site(s) may be important for regulation of the uptake activity.



Substrate Specificity and Inhibitors of the Cl-activated Glutamate Transporter

It is difficult to elucidate the substrate specificity of the glutamate transporter, because only a limited number of radioactive glutamate analogues is available commercially. Even in the case of the synaptic vesicle glutamate transporter, the substrate specificity was evaluated indirectly by measuring the spectrum of inhibition of glutamate uptake in the presence of glutamate analogues(7, 22) . As in the case of the brain synaptic vesicle glutamate transporter(9, 10, 11) , we noticed that the combined addition of glutamate and ATP caused acidification in MVs when 4 mM Cl was present in the assay medium (Fig. 4). The acidification was sensitive to bafilomycin A1 (50 nM). Furthermore, the rate of acidification became saturated depending on the glutamate concentration, the apparent K(m) value being 3 mM, which is comparable with the K(m) value (1.3 mM) obtained using the radioisotopes(6) . Some glutamate analogues, such as 1-aminocyclohexane-trans-1,3-dicarboxylic acid, showed similar ATP and Cl-dependent acidification (Fig. 4d). These results indicated that the Cl and glutamate-dependent acidification reflected glutamate uptake by MVs; the uptake of the glutamate anion through the glutamate transporter dissipated Delta, which in turn accelerated the formation of DeltapH. Therefore, we can estimate the kinetic parameters for the uptake of glutamate analogues by measuring the rate of analogue-evoked acidification.


Figure 4: Glutamate-dependent acidification of MVs. Acridine orange fluorescence was measured in 2 ml of 20 mM MOPS-Tris (pH 7.0) buffer containing 0.3 M sucrose, 2 mM magnesium acetate, 20 µg of MVs, and 2 µM acridine orange in the absence (b) or presence (a, c, and d) of 4 mM KCl. The additions were as follows: 1 mM ATP, 5 mML-glutamate, 5 mM1-aminocyclohexane-trans-1,3-dicarboxylic acid (ACHD), and 5 mM ammonium chloride.



Table 3shows the degree of acidification and the K(m) values obtained on glutamate analogue-induced acidification as described above. Aspartate, a substrate for the Na-dependent glutamate transporter in plasma membranes(23) , was not effective. Again, cyclic glutamate analogues were relatively good substrates, with higher affinity than glutamate. The cis forms of these cyclic compounds were all ineffective. Four other compounds (D-glutamate, alpha-methyl-D,L-glutamate, -methylene-D,L-glutamate, and D,L-2-amino-4-phosphonobutyric acid) caused low acidification, suggesting that these compounds act as less efficient substrates.

Inhibition of glutamate uptake by the same compounds was also examined (Table 4). Consistent with the acidification, cyclic glutamate analogues (trans form) strongly inhibited the glutamate uptake. Compounds causing acidification always inhibited glutamate uptake with a similar order of effectiveness. Other compounds, including sulfur-containing amino acids, which inhibited glutamate uptake in synaptic vesicles(22, 24) , neither affected the uptake nor caused acidification (Table 3). At more than 5 mM, these sulfur-containing amino acids partially inhibited the glutamate uptake, but the inhibition was due to the decreased driving force upon inhibition of V-ATPase (data not shown). The following glutamate analogues also neither affected glutamate uptake nor caused acidification: L-glutamate amide, D,Lalpha-hydroxyglutaric acid, 2,4-dinitrophenyl-L-glutamate, N-phthaloyl-D,Lglutamic acid, N-carboxymethylglutamic acid, N-acetyl-L-glutamic acid, N-phenacetyl-D,Lglutamic acid, N-methylpyro-D,Lglutamic acid, N-isopropylpyro-D,Lglutamic acid, ethyl-D,scap]l2-pyrrolidone-5-carboxylate, N-trimethyl-D,L-glutamate, butyl-D,Lpyroglutamate, N-dimethyl-D,Lhydroxyglutamate, N-caproyl glutamate, beta-oxyglutamate, beta-hydroxyglutamate, N-benzyloxycarbamorylglutamate, N-toluenesulfonyl-L-glutamate, and S-carboxymethyl-L-cysteine. 1-Amino-trans-3-phosphocyclopropane carboxylic acid inhibited about 40% of the glutamate uptake without acidification (Table 3), suggesting that this compound may bind to the transporter but not be transported. Taken together, these results suggested that the glutamate transporter in pineal MVs shows strict substrate recognition; a compound on the replacement of an amino group and a change in the carbon chain length of the L-glutamate moiety ceased to be a substrate. The transporter prefers a partially folded conformation of a substrate rather than an extended one. It seems likely that the transporter recognizes the configuration of the 1,3-carboxylates and 1-amino groups of cyclic glutamate analogues but is indifferent as to the length of the carbon chain on the opposite side of the cyclic molecules.


DISCUSSION

Glutamate, an excitatory neurotransmitter, is stored in synaptic vesicles, is extruded into the synaptic cleft upon stimulation, and binds to its receptors present in postsynaptic membranes so as to transmit signals intercellularly(25, 26) . The vesicular glutamate transporter in synaptic vesicles is responsible for the storage of glutamate in neurons(27, 28, 29, 30) . Like other neurotransmitter transporters, the glutamate transporter is energetically coupled with V-ATPase (27, 28, 29, 30) but uses Delta as the major driving force(9, 10, 11, 31, 32) . The chloride anion is suggested to regulate the transport activity via anion-binding site(s)(21) . However, the properties of this transporter at the molecular level remain obscure because neither purification of the transporter nor cloning of its cDNA have been successful. One of the aims of this study was to find a new approach for this fascinating transporter, because a comparative study will be possible if the vesicular glutamate transporter in pineal MVs resembles the synaptic vesicle counterpart.

As summarized, the glutamate transporter in pineal MVs is driven by Delta (positive inside) ( Fig. 2and Table 1). The spectrum of the requirement of anions for the uptake activity was essentially the same as that of the synaptic vesicle counterpart(7) . The activation by Cl or Br could be attributed to their direct interaction with the transporter, presumably via an anion-binding site ( Fig. 3and Table 2). At present, it is difficult to prove that Cl acts as a counter ion for chloride and glutamate co-transport, because we can not demonstrate Cl movement through either the glutamate transporter or the Cl channel in MVs. Furthermore, we showed that the substrate specificity of the vesicular glutamate transporter was quite similar to that of the synaptic vesicle counterpart, as judged from the inhibition of glutamate uptake by glutamate analogues(7, 22) . The overall properties of the glutamate transporters in synaptic vesicles and pineal MVs are similar to each other. We concluded that a glutamate transporter that is similar, if not identical, to the synaptic vesicle counterpart operates in MVs. Thus, pineal MVs constitute another experimental system for studies on the vesicular glutamate transporter.

Pineal MVs contain synaptobrevin and synaptotagmin, proteins important for vesicular transport(6) . Recently, we found that pinealocytes express relatively high concentrations of N-ethylmaleimide-sensitive fusion protein, Ca-channel protein, and smg25A (a small GTP-binding protein). Some of N-ethylmaleimide-sensitive fusion protein and smg25A was found to be associated with MVs. (^2)These results further support that MVs are the organelles that store L-glutamate and are involved in the glutamate-evoked signal transduction system. Released glutamate may bind to the glutamate receptor identified in pinealocytes (33, 34) and may inhibit noradrenaline-stimulated N-acetyltransferase and hydroxyindole-O-methyltransferase activities, resulting in inhibition of melatonin synthesis (35, 36, 37) .

Finally, we should point out the similarity between pinealocytes and retinal photoreceptor cells. Pinealocytes accumulate glutamate inside MVs and may extrude it through exocytosis, possibly at process terminals and/or the synaptic ribbon region ( (6) and this paper). Similarly, retinal photoreceptor cells use glutamate as a transmitter possibly via synaptic vesicle-mediated exocytosis at the ribbon synapse (38, 39) . Both types of cells lack of synapsins, suggesting that pineal MVs and retinal synsaptic vesicles move to their release sites though a novel mechanism(40) . Furthermore, pinealocytes, especially from lower vertebrates, can receive photosignals via photo-receptive molecules such as pinopsin(41) . These profound mechanistic similarities will be useful for understanding the mechanism underlying the signal transduction in pineal glands and retinal cells.

MVs from pancreatic beta cells(42) , adrenal chromaffin cells(43) , PC12 cells(44) , and posterior pituitaries (45) have been shown to accumulate -aminobutyrate, noradrenaline, acetylcholine, and noradrenaline, respectively. Upon stimulation, these transmitters may be extruded from the cells and then transmit signals intercellularly. Therefore, the presence of V-ATPase and the neurotransmitter transporter in MVs may be one of the usual features of endocrine cells.


FOOTNOTES

*
This study was supported in part by grants from the Japanese Ministry of Education, Science, and Culture. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed. Tel.: 81-848-44-1143; Fax: 81-848-44-5914.

(^1)
The abbreviations used are: MV, synaptic-like microvesicle; DIDS, 4,4`-diisothiocyanatostilbene-2,2`-disulfonic acid; DeltapH, transmembrane pH gradient; Delta, transmembrane potential difference; V-ATPase, vacuolar H-ATPase; MOPS, 4-morpholinepropanesulfonic acid; oxonol-V, bis(3-phenyl-5-oxoisoxasol-4-yl)peptamethine oxonol.

(^2)
Moriyama, Y., Yamamoto, A., Tagaya, M., Tashiro, Y., and Michibata, H.(1995) Neuroreport6, in press.


ACKNOWLEDGEMENTS

We thank Drs. Masamitsu Futai (Osaka University), Hitoshi Michibata (Hiroshima University), Yutaka Tashiro (Kansai Medical University), and Tomofusa Tsuchiya (Okayama University) for critically reading the manuscript and encouragement. We also thank Dr. Shinji Ohmori (Okayama University) for providing us with some of the glutamate analogues.


REFERENCES

  1. Axelrod, J. (1974) Science 184,1341-1348 [Medline] [Order article via Infotrieve]
  2. Reiter, R. J. (1981) Am. J. Anat. 162,287-313 [Medline] [Order article via Infotrieve]
  3. Malvin, P. V. (1993) in Mammalian Neuroendocrinology , pp. 141-160, CRC Press, Inc., Boca Raton, FL
  4. Karasek, M., and Reiter, R. T. (1992) Microscopy Res. Tech. 21,136-157
  5. Redecker, P., and Bargsten, G. (1993) J. Neurosci. Res. 34,79-96 [Medline] [Order article via Infotrieve]
  6. Moriyama, Y., and Yamamoto, A. (1995) FEBS Lett., 367, 233-236 [CrossRef][Medline] [Order article via Infotrieve]
  7. Naito, S., and Ueda, T. (1983) J. Biol. Chem. 258,696-699 [Abstract/Free Full Text]
  8. Naito, S., and Ueda, T. (1985) J. Neurochem. 44,99-109 [Medline] [Order article via Infotrieve]
  9. Maycox, P. R., Deckwerth, T., Hell, J. W., and Jahn, R. (1988) J. Biol. Chem. 263,15423-15428 [Abstract/Free Full Text]
  10. Cidon, S., and Sihra, T. S. (1989) J. Biol. Chem. 264,8281-8288 [Abstract/Free Full Text]
  11. Moriyama, Y., Maeda, M., and Futai, M. (1990) J. Biochem. (Tokyo) 108,689-693 [Abstract]
  12. Tabb, J. S., and Ueda, T. (1991) J. Neurosci. 11,1822-1828 [Abstract]
  13. Roseth, S., and Fonnum, F. (1995) Neurosci. Lett. 183,62-66 [CrossRef][Medline] [Order article via Infotrieve]
  14. Moriyama, Y., and Nelson, N. (1987) J. Biol. Chem. 262,9175-9180 [Abstract/Free Full Text]
  15. Uchida, E., Ohsumi, Y., and Anraku, Y. (1985) J. Biol. Chem. 260,1090-1095 [Abstract/Free Full Text]
  16. Van Dyke, R. W. (1988) J. Biol. Chem. 263,2603-2611 [Abstract/Free Full Text]
  17. Nelson, N. (1989) J. Bioenerg. Biomembr. 21,553-572 [Medline] [Order article via Infotrieve]
  18. Forgac, M. (1989) Physiol. Rev. 69,765-796 [Free Full Text]
  19. Xie, X.-S., Crider, B. P., and Stone, D. K. (1989) J. Biol. Chem. 264,18870-18873 [Abstract/Free Full Text]
  20. Moriyama, Y., and Nelson, N. (1988) J. Biol. Chem. 263,8521-8527 [Abstract/Free Full Text]
  21. Hartinger, J., and Jahn, R. (1993) J. Biol. Chem. 268,23122-23127 [Abstract/Free Full Text]
  22. Winter, H. C., and Ueda, T. (1993) Neurochem. Res. 18,79-85 [Medline] [Order article via Infotrieve]
  23. Kanner, B. I., and Sharon, I. (1978) Biochemistry 17,3949-3953 [Medline] [Order article via Infotrieve]
  24. Dunlop, J., Fear, A., and Griffiths, R. (1991) Neuroreport 2,377-379 [Medline] [Order article via Infotrieve]
  25. Fonnum, F. (1984) J. Neurochem. 42,1-11 [Medline] [Order article via Infotrieve]
  26. Mayer, M. L., and Westbrook, G. L. (1987) Prog. Neurobiol. (Oxf.) 28,197-276 [CrossRef][Medline] [Order article via Infotrieve]
  27. Ueda, T. (1986) in Excitatory Amino Acids (Robert, P. J., Storm-Mathisen, J., and Branford, H. F., eds) pp. 173-195, MacMallian Press, New York
  28. Maycox, P. R., Hell, J. W., and Jahn, R. (1990) Trends Neurosci. 13,83-87 [CrossRef][Medline] [Order article via Infotrieve]
  29. Schuldiner, S., Shirvan, A., and Linial, M. (1995) Physiol. Rev., 75, 369-392 [Free Full Text]
  30. Moriyama, Y., Maeda, M., and Futai, M. (1992) J. Exp. Biol. 172,171-179 [Abstract/Free Full Text]
  31. Shioi, J., Naito, S., and Ueda, T. (1990) Biochem. J. 267,63-68 [Medline] [Order article via Infotrieve]
  32. Tabb, J. S., Kish, P. E., Van Dyke, R., and Ueda, T. (1992) J. Biol. Chem. 267,15412-15418 [Abstract/Free Full Text]
  33. Ebadi, M., Govitrapong, P., and Murrin, L. C. (1986) in Advance in Pineal Research (Reiter, R. J., and Karasek, M., eds) pp. 99-109, John Libbey & Co., Ltd., New York
  34. Kus, L., Handa, R. J., and McNulty, J. A. (1993) J. Pineal Res. 14,39-44 [Medline] [Order article via Infotrieve]
  35. Govitrapong, P., and Ebadi, M. (1988) Neurochem. Int. 13,223-230 [CrossRef]
  36. van Wyk, E., and Daya, S. (1994) Med. Sci. Res. 22,635-636
  37. Kus, L., Handa, R. J., and McNulty, J. A. (1994) J. Neurochem. 62,2241-2245 [Medline] [Order article via Infotrieve]
  38. Oksche, A. (1986) in Pineal and Retinal Relationships (O'Brien, P. J., and Klein, D. C., eds) pp. 1-14, Academic Press, Orlando, FL
  39. DeVies, S. H., and Baylor, D. A. (1993) Cell 72,(suppl.) 139-149 [Medline] [Order article via Infotrieve]
  40. Mandell, J. W., Townes-Anderson, E., Czernik, A. J., Cameron, R., Greengard, P., and De Camilli, P. (1990) Neuron 5,19-33 [Medline] [Order article via Infotrieve]
  41. Okano, T., Yoshizawa, T., and Fukada, Y. (1994) Nature 372,94-97 [CrossRef][Medline] [Order article via Infotrieve]
  42. Thomas-Reetz, A., Hell, J. W., During, M. J., Walch-Solimena, C., Jahn, R., and De Camilli, P. (1993) Proc. Natl. Acad. Sci. U. S. A. 90,5317-5321 [Abstract]
  43. Annaert, W. G., Llona, I., Backer, A. C., Jacob, W. A., and De Potter, W. P. (1993) J. Neurochem. 60,1746-1754 [Medline] [Order article via Infotrieve]
  44. Toll, L., and Howard, B. D. (1980) J. Biol. Chem. 255,1787-1789 [Abstract/Free Full Text]
  45. Moriyama, Y., Yamamoto, A., Yamada, H., Tashiro, Y., Tomochika, K., Takahashi, M., Maeda, M., and Futai, M. (1995) J. Biol. Chem. 270,11424-11429 [Abstract/Free Full Text]
  46. Moriyama, Y., Takano, T., and Ohkuma, S. (1982) J. Biochem. 92,1333-1336 [Abstract]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.